Ringr Featured on Shoutmeloud.com

Ringr, a Serra Capital II portfolio company, was featured on shoutmeloud.com on September 15. Ringr offers a free and premium software application which allows users to record studio-quality audio interviews. The technology eliminates staticky phone calls on the radio or warbly internet audio on podcasts. The Ringr technology changes the whole interview experience.

The article showcases how with Ringr, you can record a podcast Interview with a guest using nothing but a smartphone. 

Source: https://www.shoutmeloud.com/ringr-review.html

Nanomedical Diagnostics' Agile R100 Detects Zika

Nanomedical Diagnostics, a Serra Capital II portfolio company, has announced a new publication in Biosensors and Bioelectronics demonstrating detection of Zika viral antigen using their label-free Agile R100 biosensor.  Nano is a cutting-edge life science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development.

The Zika virus, a mosquito-borne infection, has been shown to be a cause of microcephaly and other severe fetal brain defects. For pregnant women, it is especially important to reliably identify Zika virus infection in a timely manner, but current methods show high false positive rates and can take weeks to return test results. The compact and portable Agile R100 represents a potential methodology to identify Zika infection promptly.

Curematch Co-founders Study the molecular Alterations of Genes to Develop Personalized Cancer Therapy Options

CureMatch, a Serra Capital III portfolio company, has recently published a study in the journal of Cancer Biology & Therapy. CureMatch is a digital health company focused on personalized medicine and combination therapy in oncology.

The study conducted by CureMatch highlighted the role of a specific molecular mutation in eosinophilic cystitis, and how their methods might better treat this type of condition. 

Source: http://www.prnewswire.com/news-releases/curematch-co-founders-study-the-molecular-alterations-of-genes-to-develop-personalized-cancer-therapy-options-300516362.html

Chicago Timmy Awards Selects Label Insight a Best Tech Startup Finalist

Label Insight, a Serra Capital II portfolio company, was recently ecognized by Tech in Motion as one of the best technology startups in Chicago. Label Insight is the market leader for transparency, enabling access to complete and accurate product information for more than 400,000 products, representing 80 percent of the top purchased CPG products in the U.S.

"The Timmy Awards aim to celebrate the companies and managers that make that technological innovation possible," said Mandy Walker, director of marketing at Tech in Motion and Motion Recruitment Partners. "Since the Timmy Awards were created in 2015, over 400 finalists have been celebrated for creating work environments that enable growth in the technology of various industries."

Source: http://www.prnewswire.com/news-releases/chicago-timmy-awards-selects-label-insight-as-a-best-tech-startup-finalist-300511985.html

HomeBay Rewriting the Rules of Engagement in Real Estate

HomeBay, a Serra Capital III portfolio company, was recently listed in a piece on The Lenders Network as one of five fintech companies that is changing the way people engage in real estate. HomeBay helps sellers to navigate the real estate process via automated & live help to make the listing, selling and closing processes faster, easier and less stressful. The company also puts homes in front of millions of buyers by syndicating the listings to the MLS and the most popular real estate sites across the web.

The article features HomeBay's platform, which allows regular homeowners to sell like professionals without the high costs of engaging a real estate agent.

Source: https://thelendersnetwork.com/5-fintechs-rewriting-the-rules-of-engagement-in-real-estate/

WhiteFox’s counter-drone technology tested this week at U.S. military base

WhiteFox Defense Technologies, a Serra Capital III portfolio company, recently demonstrated their flagship product, the DroneFox, to a range of U.S. military leaders during the Joint Interagency Field Experimentation (JIFX) program. 

Drones pose a present and evolving danger to people and property. WhiteFox Defense Technologies, Inc. has developed a comprehensive, intuitive, portable drone interception device called the DroneFox to counteract these threats.

Source: https://www.suasnews.com/2017/08/whitefoxs-counter-drone-technology-tested-this-week-at-u-s-military-base/

Hercutech's Breakout Year

Hercutech, a Serra Capital I and II company, was featured on builderonline.com on August 21. Hercutech manufactures and markets HercuWall, a panelized concrete wall system that is used in lieu of concrete block wall and wood frame construction in new residential and commercial building structures. HercuWall is the product of years of engineering, development, and testing resulting in a building technology that exceeds concrete block wall construction in strength, performance and speed of installation.

After 8 years of hard work getting their ground-breaking technology to the market, CEO Michael Neimann is finally getting his breakout year. If the product is adopted, it is one that "could change, in pretty short order, a lot of the conversation we've been having about home builders and economic productivity."

Source: http://www.builderonline.com/building/wall-talk-a-building-envelope-of-tomorrow_o

Serra Capital Invests in CureMatch

CureMatch, a digital health company focusing on personalized medicine and combination therapy in oncology, is Serra Capital III's 13th investment. Serra is participating in the company's Bridge to Series A round. 

"CureMatch represents a unique, breakthrough opportunity in the treatment of cancer, a disease that touches all of our lives in some way," said Steve Beck, Managing Partner at Serra Venture's San Diego office. "The company's solution resides at the intersection of precision medicine and actionable intelligence extracted from big data. We're confident that the CureMatch team is poised to lead the way in personalized cancer treatment, and we are thrilled to add them to the Serra Ventures' portfolio."

Source: http://www.biospace.com/news_story.aspx?StoryID=466700

Serra Ventures Publishes New White Paper on SBIC

The Serra Capital III (SBIC) fund officially launched fundraising efforts in July 2017 after receiving the “green-light” letter from the SBA. With a rigorous underwriting and approval process, the Serra Ventures team is very pleased to be accepted into this program and eager to begin accepting commitments. Throughout this process, we have been approached with a variety of questions. What is an SBIC Fund? Why invest in an SBIC Fund? How does the SBIC Fund differ from its sister fund, Serra Capital III? This high level white paper will address these questions - and explain why an SBIC Fund is attractive for banks and non-bank investors alike.

Reconstruct Featured in Champaign News-Gazette

Reconstruct, a Serra Capital III portfolio company, was recently featured in the Champaign News-Gazette's Wired In Business section on August 14.  Reconstruct uses new computer techniques to improve efficiency and reduce risk in construction.

Each week, Wired In interviews a new "high-tech difference maker" and this week's individual was  Reconstruct CTO Derek Hoiem. The article further explained how the company's technology works, and the future of Reconstruct. 

Source: http://www.news-gazette.com/news/business/2017-08-13/wired-derek-hoiem.html

Clarify Medical Publishes Form D for $5M Equity Financing

Clarify Medical, a Serra Capital III portfolio company, has just published a new filing - a Form D $5M Equity Financing. Clarify Medical is a connected device that uses cutting edge LED technology to bring personal, private prescription phototherapy to patients with psoriasis, eczema and vitiligo. Clarify brings handheld, guided therapy to millions of patients, while staying wirelessly connected to physicians and dermatologists. Clarify Medical improves care by bringing convenient, low-cost therapy into a patient’s home.

For more information on Form D's and what they are used for, and to learn more about Clarify Medical, follow the link below. 

Source: http://presstelegraph.com/clarify-medical-5-00-million-fundraising-james-m-sweeney-published-jul-20-filing/

Label Insight Reports Strong Customer Momentum for Transparency Initiatives

Label Insight, a Serra Capital II portfolio company, has reported tremendous customer growth in Q2 2017 for its data transparency solutions. Label Insight's mission is helping consumers understand what’s in the products they use and consume, and has built a platform to help brands and retailers better understand their own product data in order to pass that information along to consumers, giving them the power to make informed purchasing decisions. 

Label Insight has made deals with several new CPG manufacturers and retailers that will help those organizations respond to the consumer mandate for greater transparency - including PepsiCo, Schnucks, and Ocean Spray Cranberries.

Source: http://www.prnewswire.com/news-releases/label-insight-reports-strong-customer-momentum-for-transparency-initiatives-in-q2-300493342.html

TPM Featured in Champaign News-Gazette

The Product Manufactory (TPM), a Serra Capital I portfolio company, was featured in the Champaign News-Gazette on July 14. TPM offers professional design and engineering services for customers performing product development. The services side of TPM works on a contract basis and engages with customers to develop concepts and prototypes based on their specifications and requirements.

Out of all the products that TPM has created since the company's inception, the focus of this particular article was a new smart oven - one that automatically knows how to cook healthy, fresh ingredients into multi-course meals simply by reading a bar code.

"We received lots of incredible feedback and suggestions," Bryan Wilcox, CEO of TPM said. "Because we make a lot of use of technology and software elements, we're able to update the behavior of the appliances."

Source: http://www.news-gazette.com/news/local/2017-07-14/new-smart-oven-partially-cooked-urbana.html

Serionix Featured in Crain's Chicago Business

Serionix, a Serra Capital I and III company, was recently featured in Crain's Chicago Business on July 6. Serionix develops high performance, affordable technologies for water and air purification. Using fibrous activated carbon and ion-exchange materials, Serionix purification is differentiated by rapid rates of contaminant uptake, well-defined selectivity for targeted chemicals, and potential for low-cost production. The inventors of this air filter continue to find new uses for it, from purifying the air astronauts breathe to eliminating the smell of cat urine.

Highlights from Serionix include a $750,000 contract from NASA to continue to develop filters for potential use in next-generation spacesuit life-support systems. The company has also received a total of $3 million in grants as well as more than $500,000 from its lead investor, Serra Ventures.

Source: http://www.chicagobusiness.com/article/20170706/ISSUE01/170709985/serionix-invents-air-filters-for-nasa-and-to-eliminate-cat-urine

Farmlead NameD to 25 Most Innovative Ag-Tech Startups by Forbes

Farmlead, a Serra Capital III portfolio company, was recently listed among Forbes "25 Most Innovative Ag-Tech Startups." Farmlead is a digital marketplace that allows buyers and sellers to list, negotiate and finalize grain deals. Available online and as a mobile app,  FarmLead increases market reach, provides 24-7 access and reduces brokerage fees. The FarmLead Marketplace facilitates greater efficiency in grain marketing. 

To find the 25 ag-tech startups that carry the most potential, Forbes surveyed the agricultural technology landscape by speaking with experts, venture capitalists and accelerators; then examined financials and each company’s agricultural credentials. 

Source: https://www.forbes.com/sites/maggiemcgrath/2017/06/28/the-25-most-innovative-ag-tech-startups/#227178fb4883

12 Labs CEO Featured in Tech.Co

Ashu Dubey, Co-Found of 12 Labs, a Serra Capital II company, was recently featured in a blog piece on Tech.Co. The article was titled "How to Build an In-House Data Science Team From Scratch." 12 Labs' flagship product is the Applause health app. Applause is the most effective tool in your battle to lose weight. (And unlike other weight loss programs, Applause fits in the palm of your hand). Applause uses data science algorithms and behavioral psychology to make suggestions and predictions specifically for you. 

Ashu Dubey is a product guy, hacker and data scientist all rolled into one. He is the co-founder of 12 Labs’ Applause, a data science powered weight loss application. At 12 Labs, he crunches data to help Applause users lose weight smartly and scientifically.

Source: https://tech.co/author/ashu-dubey

Tunespeak Featured in Forbes

Tunespeak, a Serra Capital II portfolio company, was recently featured in an article on Forbes.com. Tunespeak is a musician-to-fan reward platform that is the brainchild of two St. Louis musicians. Tunespeak connects bands to their most loyal and influential fans, rewarding fans for listening, sharing and promoting bands on their existing social media networks.

The article outlines just how Tunespeak wants to help modernize the idea of a street team to assist musicians at all points in their careers to spread the word about what they are up to and help increase their fan base. Tom Pernikoff, CEO and co-founder of Tunespeak, explained the goal of his company is “as much about keeping artists top of mind and selling things as making sure fans are being recognized."

Source: https://www.forbes.com/sites/hughmcintyre/2017/06/26/tunespeak-rewards-fans-for-promoting-the-bands-they-already-love/#467e82021822

Homebay Successfully Completes $5M Funding

HomeBay, a Serra Capital III portfolio company, announced on June 26 that it has successfully completed a $5M round of funding. HomeBay, a San Diego based company, provides consumers a smarter way to buy and sell homes with data-driven intelligence, complete transparency and an on-demand customer experience. Home Bay’s sophisticated technology platform expedites the transaction with efficient, seamless systems that save consumers and real estate agents time and money.

The company plans to use the financing for expansion into new markets. Serra Capital III participated in the round. 

Source: http://www.prweb.com/releases/homebay/homesforsalebyowner/prweb14448519.htm

Serra Capital III Invests in WhiteFox Defense Technologies

Serra Capital III is pleased to announce its 13th investment in WhiteFox Defense Technologies. Drones pose a present and evolving danger to people and property. Mitigating a drone threat in any protection mission requires a dynamic and reliable kill chain response to ensure a controlled landing. WhiteFox Defense Technologies, Inc. has developed a comprehensive, intuitive, portable drone threat mitigation device—the DroneFox.

Luke Fox, CEO of WhiteFox, says “WhiteFox is at a point of growth where our technology is critically needed and in high demand. Every DroneFox we sell will represent an entity being equipped to protect people and property from threats to security, safety, and even loss of life posed by drones. Our partnership with Serra will help us further accelerate delivery of this critically needed technology.”

“The team at Serra Ventures is honored to be partnering with Luke Fox and the executives over atWhiteFox Defense Technologies” says Steve Beck, Managing Partner at Serra Ventures. “WhiteFox has cracked the code on some seriously deep technology challenges to elevate protection capabilities for both the Department of Defense and the private sector in response to the ever growing threat of reckless and dangerous drone incursions. This technology is essential for both public and national security as well as the appropriate expansion of commercial drone use.”

Clarify Medical Receives FDA Clearance

Clarify Medical, a Serra Capital III portfolio company, has received FDA clearance for its main technology - The Clarify Medical Phototherapy System, which is the core technology of its Clarify Home Light Therapy service. Clarify’s proprietary technology allows patients with chronic skin diseases to receive UVB phototherapy in their homes, linked to their physicians and to Clarify support services through their smartphones. The company plans to start offering the technology in November of 2017.

“This is a major milestone,” said James M. Sweeney, Clarify Medical’s CEO. “We look forward to offering Clarify Home Light Therapy to patients throughout the country, beginning in November. It offers an in-office therapy proven effective with skin diseases such as psoriasis, vitiligo, and eczema in a convenient form.”

Source: http://www.businesswire.com/news/home/20170606005075/en/Clarify-Medical-Core-Technology-Receives-FDA-Clearance